273 related articles for article (PubMed ID: 15712019)
1. [Prevalence and pharmacotherapy of diabetes mellitus in primary care].
Lehnert H; Wittchen HU; Pittrow D; Bramlage P; Kirch W; Böhler S; Höfler M; Ritz E
Dtsch Med Wochenschr; 2005 Feb; 130(7):323-8. PubMed ID: 15712019
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
3. [How many and who are receiving medication for diabetes mellitus?].
Strøm H; Engeland A; Eriksen E; Sakshaug S; Rønning M
Tidsskr Nor Laegeforen; 2006 Mar; 126(6):768-70. PubMed ID: 16541171
[TBL] [Abstract][Full Text] [Related]
4. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents.
Liberman JN; Berger JE; Lewis M
Arch Pediatr Adolesc Med; 2009 Apr; 163(4):357-64. PubMed ID: 19349565
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of urolithiasis: a link between stone formation and diabetes mellitus?
Zimmerer T; Weiss C; Hammes HP; Braun C; Hesse A; Alken P; Knoll T
Urol Int; 2009; 82(3):350-5. PubMed ID: 19440027
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
[TBL] [Abstract][Full Text] [Related]
9. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
10. [Quality of diabetes care in Norwegian general practice].
Claudi T; Ingskog W; Cooper JG; Jenum AK; Hausken MF
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2570-4. PubMed ID: 19023353
[TBL] [Abstract][Full Text] [Related]
11. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
[TBL] [Abstract][Full Text] [Related]
12. [The increase in the use of drug treatment for diabetes mellitus in the Netherlands, 1998-2003].
Langendam MW; Hooijkaas C; Piepenbrink JF
Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1396-401. PubMed ID: 16841589
[TBL] [Abstract][Full Text] [Related]
13. Evidence of an increasing prevalence of diagnosed diabetes mellitus in the Poole area from 1983 to 1996.
Gatling W; Budd S; Walters D; Mullee MA; Goddard JR; Hill RD
Diabet Med; 1998 Dec; 15(12):1015-21. PubMed ID: 9868974
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
Cortez-Dias N; Martins S; Belo A; Fiuza M;
Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569
[TBL] [Abstract][Full Text] [Related]
15. [Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care].
Scholze J; Lilienthal W; Bramlage P
MMW Fortschr Med; 2007 Sep; 149 Suppl 3():103-10. PubMed ID: 17955787
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).
Hauner H; Hanisch J; Bramlage P; Steinhagen-Thiessen E; Schunkert H; Jöckel KH; Wasem J; Moebus S
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):18-25. PubMed ID: 17926235
[TBL] [Abstract][Full Text] [Related]
17. [Patient classification and analysis of risk profiles for type 2 diabetics as the main focus point in practice. Results of the TEMPO study].
Lippmann-Grob B; Bierwirth RA; Kron P; Leinhos B; Funke K; Huptas M; Grüneberg M; Weich KW; Münscher C; Potthoff F
Dtsch Med Wochenschr; 2004 Jan; 129(3):75-81. PubMed ID: 14724780
[TBL] [Abstract][Full Text] [Related]
18. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
Aquilante CL; Zhang W; McCollum M
Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730
[TBL] [Abstract][Full Text] [Related]
19. Using a pharmaco-epidemiological approach to estimate diabetes type 2 prevalence in Portugal.
Duarte-Ramos F; Cabrita J
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):269-74. PubMed ID: 16294365
[TBL] [Abstract][Full Text] [Related]
20. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
